Cantel Medical Closes Sale of Carsen Assets to Olympus America Inc.
LITTLE FALLS, N.J.-- Cantel Medical Corp. announces the closing of the sale of assets by its Carsen subsidiary to Olympus America Inc. under an agreement dated as of May 16, 2006. Carsen sold all of its assets to Olympus other than those related to its Medivators business and several other smaller product lines. Following the closing, Olympus Canada hired Carsen's employees and took over Carsen's Olympus-related operations. The purchase price for the net assets sold to Olympus was approximately $31.5 million.
Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market; products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, and specialty packaging for infectious and biological specimens.
Source: Cantel Medical Corp.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
